| The Efficacy and Safety of HLX208 in Adult Langerhans Cell Histiocytosis (LCH) and Erdheim-Chester Disease (ECD) With BRAF V600E Mutation (NCT05092815) | Shanghai Henlius Biotech | 2021-12-06 |
| LCH in Adults: a Collaborative, Prospective-retrospective, Observational Study (NCT04627090) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2021-03-15 |
| Thalidomide, Cyclophosphamide and Dexamethasone for Recurrent/Refractory Adult Langerhans Cell Histiocytosis (NCT04120519) | Peking Union Medical College Hospital | 2019-10-10 |
| AraC for Newly Diagnosed Adult Langerhans Cell Histiocytosis (NCT04121819) | Peking Union Medical College Hospital | 2019-10-01 |
| A Prospective Study for the Treatment of Children With Newly Diagnosed LCH Using a Cytarabine Contained Protocol (NCT04773366) | Shanghai Children's Medical Center | 2018-07-01 |
| A Combination of Vemurafenib, Cytarabine and 2-chlorodeoxyadenosine in Children With LCH and BRAF V600E Mutation (NCT03585686) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2018-06-26 |
| Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) (NCT03220035) | National Cancer Institute (NCI) | 2017-11-08 |
| Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma (NCT03096782) | M.D. Anderson Cancer Center | 2017-10-13 |
| Denosumab for the Treatment of Adult LCH (NCT03270020) | Hellenic Society for the Study of Bone Metabolism | 2017-09-07 |
| Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) (NCT03155620) | National Cancer Institute (NCI) | 2017-07-31 |
| LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis (NCT02205762) | North American Consortium for Histiocytosis | 2016-11-02 |
| Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH) (NCT02670707) | Baylor College of Medicine | 2016-03-07 |
| Evaluation of Exercise Capacity and Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis (NCT02665546) | InCor Heart Institute | 2016-03-01 |
| Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement (NCT02608619) | Memorial Sloan Kettering Cancer Center | 2015-11-01 |
| Methotrexate and Cytosine in Adult Langerhans Cell Histiocytosis (NCT02389400) | Peking Union Medical College Hospital | 2014-01-01 |
| Central China Rosai-Dorfman Disease Registry (NCT05284942) | Tongji Hospital | 2011-10-01 |
| Stem Cell Transplant for Immunologic or Histiocytic Disorders (NCT00176865) | Masonic Cancer Center, University of Minnesota | 2002-08-01 |
| T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders (NCT00176826) | Masonic Cancer Center, University of Minnesota | 2000-09-01 |
| Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH (NCT00588536) | Memorial Sloan Kettering Cancer Center | 1995-01-01 |
| Clofarabine for Langerhans in Pedi (NCT01796405) | Dana-Farber Cancer Institute | |